MedTrace Logo

A Multi-centre Study Comparing the Effects of AZD2927 and Placebo on the Electrical Activity in the Heart in Patients

NCT01396226 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2012-11-27

Study results available
· View outcomes & findings →

Summary

Medical Products Agency

Conditions

Interventions

DRUG

AZD2927

A single dose of AZD2927 administered as an iv infusion

DRUG

Placebo

A single dose of placebo administered as an iv infusion

Sponsors & Collaborators

Principal Investigators

  • Stefan C Carlsson, MD, PHD · AstraZeneca

  • Hakan Walfridsson, MD, PHD · University Hospital Linkoping Sweden

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2012-01-31
Completion
2012-01-31

Countries

  • Norway
  • Sweden

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01396226 on ClinicalTrials.gov